Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Recursion Pharmaceuticals is a clinical-stage biotechnology company that industrializes drug discovery by integrating technology across biology, chemistry, and data science. They are developing multiple drug candidates for various diseases, including cerebral cavernous malformation, neurofibromatosis type 2, and certain cancers. Recursion partners with major pharmaceutical companies to advance its pipeline.
AI-generated summary. Not investment advice.